FLAT-SUGAR Published: GLP- Agonist Reduces Glucose Variability in Diabetics

Insulin-dependent type 2 diabetes patients at high cardiovascular risk show reduced glucose variability (GV) when treated with a glucagon-like peptide 1 receptor agonist (GLP-1RA), a new proof-of-concept study shows.